Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Schumann

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
AIDS and Behavior|February 22, 2019
Effect of Patient Navigation on Transitions of HIV Care After Release from Prison: A Retrospective Cohort StudyRyan P Westergaard, Karli R Hochstatter, Paige N Andrews, et al.
JACC. Cardiovascular Imaging|April 18, 2021
Functional and Economic Impact of INOCA and Influence of Coronary Microvascular DysfunctionChristopher L Schumann, Roshin C Mathew, John-Henry L Dean, et al.
Drug and Alcohol Review|December 7, 2025
The Emergence of Novel Benzodiazepines in Australia, Evidence, Alerts, Clinical Management and Harm Reduction-A Narrative ReviewJack Freestone, Stassi Kypri, Jennifer L Schumann, et al.
The International Journal on Drug Policy|November 9, 2023
Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia - Victoria project 2020-2022Rebekka Syrjanen, Shaun L Greene, Courtney Weber, et al.
Drug and Alcohol Review|September 6, 2022
What are the research priorities for optimising the safe and effective use of opioids in Australian general practice?Monica Jung, Helena Cangadis-Douglass, Suzanne Nielsen, et al.
Drug and Alcohol Review|June 16, 2026
Accuracy of Patient-Reported Exposure to New Psychoactive Substances and Other Illicit Drugs in Australian Emergency Departments: Findings From the Emerging Drugs Network of AustraliaMarjan J Nijmeijer, Jennifer L Smith, Courtney Weber, et al.
Science (New York, N.Y.)|July 31, 2025
<i>Escherichia coli</i> with a 57-codon genetic codeWesley E Robertson, Fabian B H Rehm, Martin Spinck, et al.
The International Journal on Drug Policy|August 23, 2025
Novel psychoactive substances in Australian emergency departments: implications for public health practice from multi-centre prospective toxicosurveillance across five states, 2022-2023Jennifer L Smith, Courtney C Weber, Jennifer L Schumann, et al.
Acta Cytologica|February 28, 1998
Quality assurance/control issues. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and TutorialP A Krieger, E McGoogan, G P Vooijs, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
AIDS and Behavior|February 22, 2019
Effect of Patient Navigation on Transitions of HIV Care After Release from Prison: A Retrospective Cohort StudyRyan P Westergaard, Karli R Hochstatter, Paige N Andrews, et al.
JACC. Cardiovascular Imaging|April 18, 2021
Functional and Economic Impact of INOCA and Influence of Coronary Microvascular DysfunctionChristopher L Schumann, Roshin C Mathew, John-Henry L Dean, et al.
Drug and Alcohol Review|December 7, 2025
The Emergence of Novel Benzodiazepines in Australia, Evidence, Alerts, Clinical Management and Harm Reduction-A Narrative ReviewJack Freestone, Stassi Kypri, Jennifer L Schumann, et al.
The International Journal on Drug Policy|November 9, 2023
Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia - Victoria project 2020-2022Rebekka Syrjanen, Shaun L Greene, Courtney Weber, et al.
Drug and Alcohol Review|September 6, 2022
What are the research priorities for optimising the safe and effective use of opioids in Australian general practice?Monica Jung, Helena Cangadis-Douglass, Suzanne Nielsen, et al.
Drug and Alcohol Review|June 16, 2026
Accuracy of Patient-Reported Exposure to New Psychoactive Substances and Other Illicit Drugs in Australian Emergency Departments: Findings From the Emerging Drugs Network of AustraliaMarjan J Nijmeijer, Jennifer L Smith, Courtney Weber, et al.
Science (New York, N.Y.)|July 31, 2025
<i>Escherichia coli</i> with a 57-codon genetic codeWesley E Robertson, Fabian B H Rehm, Martin Spinck, et al.
The International Journal on Drug Policy|August 23, 2025
Novel psychoactive substances in Australian emergency departments: implications for public health practice from multi-centre prospective toxicosurveillance across five states, 2022-2023Jennifer L Smith, Courtney C Weber, Jennifer L Schumann, et al.
Acta Cytologica|February 28, 1998
Quality assurance/control issues. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and TutorialP A Krieger, E McGoogan, G P Vooijs, et al.
Pageof 12